In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye

Applied Optics

Volumn 47, Issue 31, 2008, Pages 5944-5952

  Foster, Aaron E ^a   Kwon, Sunkuk ^b   Ke, Shi ^b   Lu, An ^a   Eldin, Karen ^a   Sevick Muraca, Eva ^b   Rooney, Cliona M ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Department of Radiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; INFRARED DEVICES; TUMORS; VIRUSES;

CYTOTOXIC T LYMPHOCYTES; EPSTEIN-BARR VIRUS; NEAR-INFRARED DYES; REPORTER MOLECULES; SMALL ANIMAL MODEL; SPECIFIC MIGRATION; SUBCUTANEOUS TUMOR; TAIL VEIN INJECTIONS;

T-CELLS;

FLUORESCENT DYE;

ANIMAL; ARTICLE; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MOUSE; NEAR INFRARED SPECTROSCOPY; OPTICS; SPECTROFLUOROMETRY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; OPTICS AND PHOTONICS; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; T-LYMPHOCYTES, CYTOTOXIC;

EID: 60649108303     PISSN: 1559128X     EISSN: 15394522     Source Type: Journal    
DOI: 10.1364/AO.47.005944     Document Type: Article

References (28)

1. C. M. Rooney, C. A, Smith, C. Y. Ng, S. Loftin, C. Li, R. A. Krance, M. K Brenner, and H. E. Heslop, "Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation," Lancet 345, 9-13 (1995).
2. H. E, Heslop, C. Y, Ng, C, Li, C. A, Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney, "Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes," Nat. Med. 2, 551-555 (1996).
3. C. Yee, J. A. Thompson, P. Roche, D. R. Byrd, P. P. Lee, M. Piepkorn, K. Kenyon, M. M. Davis, S. R. Riddell, and P. D. Greenberg, "Melanocyte destruction after antigenspecific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo," J. Exp. Med. 192, 1637-1644 (2000).
4. 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response," Cancer Res. 73, 1731-1737 (1994).
5. M. S. Mitchell, D. Darrah, D. Yeung, S. Halpern, A. Wallace, J. Voland, V. Jones, and J. Kan-Mitchell, "Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope," J. Clin. Oncol. 20, 1075-1086 (2002).
6. N. Meidenbauer, J. Marienhagen, M. Laumer, S. Vogl, J. Heymann, R. Andreesen, and A. Mackensen, "Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients," J. Immunol. 170, 2161-2169 (2003).
7. C. Botti, D. R. Negri, E. Seregni, V. Ramakrishna, F. Arienti, L. Maffioli, C. Lombardo, A. Bogni, C. Pascali, F. Crippa, S. Massaron, F. Remonti, S. Nerini-Molteni, S. Canevari, and E. Bombardieri, "Comparison of three different methods for radiolabelling human activated T lymphocytes," Eur. J. Nucl. Med. Mol. Imaging 24, 497-504 (1997).
8. J. Hardy, M. Edinger, M. H. Bachmann, R. S. Negrin, C. G. Fathman, and C. H. Contag, "Bioluminescence imaging of lymphocyte trafficking in vivo," Exp. Hematol. 29, 1353-1360 (2001).
9. A. Nakajima, C. M. Seroogy, M. R. Sandora, I. H. Tarner, G. L. Costa, C. Taylor-Edwards, M. H. Bachmann, C. H. Contag, and C. G. Fathman, "Antigen-specific T cellmediated gene therapy in collagen-induced arthritis," J. Clin. Invest. 107, 1293-1301 (2001).
10. G. L. Costa, M. R. Sandora, A. Nakajima, E. V. Nguyen, C. Taylor-Edwards, A. J. Slavin, C. H. Contag, C. G. Fathman, and J. M. Benson, "Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit," J. Immunol. 167, 2379-2387 (2001).
11. C. E. Brown, R. P. Vishwanath, B. Aguilar, R. Starr, J. Najbauer, K S. Aboody, and M. C. Jensen, "Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells," J. Immunol. 179, 3332-3341 (2007).
12. J. Vera, B. Savoldo, S. Vigouroux, E. Biagi, M. Pule, C. Rossig, J. Wu, H. E. Heslop, C. M. Rooney, M. K. Brenner, and G. Dotti, "T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells," Blood 108, 3890-3897 (2006).
13. B. Ballou, L. A. Ernst, and A. S. Waggoner, "Fluorescence imaging of tumors in vivo," Curr. Med. Chem. 12, 795-805 (2005).
14. A. Moore, J. Grimm, B. Han, and P. Santamaria, "Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time," Diabetes 53, 1459-1466 (2004).
15. S. A. Anderson, J. Shukaliak-Quandt, E. K. Jordan, A. S. Arbab, R. Martin, H. McFarland, and J. A. Frank, "Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis," Ann. Neurol. 55, 654-659 (2004).
16. C. Billotey C. Aspord, O. Beuf, E. Piaggio, F Gazeau, M. F Janier, and C. Thivolet, "T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging," Radiology (Oak Brook, Ill.) 236, 579-587 (2005).
17. G. Koehne, M. Doubrovin, E. Doubrovina, P. Zanzonico, H. F Gallardo, A. Ivanova, J. Balatoni, J. Teruya-Feldstein, G. Heller, C. May, V. Ponomarev, S. Ruan, R. Finn, R. G. Blasberg, W Bornmann, I. Riviere, M. Sadelain, R. J. O'Reilly, S. M. Larson, and J. G. Tjuvajev, "Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigenspecific lymphocytes," Nat. Biotechnol. 21, 405-413 (2003).
18. M. M. Doubrovin, E. S. Doubrovina, P. Zanzonico, M. Sadelain, S. M. Larson, and R. J. O'Reilly, "In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene," Cancer Res. 67, 11959-11969 (2007).
19. J. V. Frangioni, "In vivo near-infrared fluorescence imaging," Curr. Opin. Chem. Biol. 7, 626-634 (2003).
20. F. K. Swirski, C. R. Berger, J. L. Figueiredo, T. R. Mempel, U. H. von Andrian, M. J. Pittet, and R. Weissleder, "A nearinfrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses," PLoS ONE 2(10), e1075 (24 October 2007).
21. W. Wang, S. Ke, Q. Wu, C. Charnsangavej, M. Gurfinkel, J. G. Gelovani, J. L. Abbruzzese, E. M. Sevick-Muraca, and C. Li, "Near-infrared optical imaging of integrin αvB3 in human tumor xenografts," Mol. Imaging 3, 343-351 (2004).
22. J. P. Houston, S. Ke, W. Wang, C. Li, and E. M. Sevick-Muraca, "Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe," J. Biomed. Opt. 10, 054010 (2005).
23. S. Ke, X. Wen, M. Gurfinkel, C. Charnsangavej, S. Wallace, E. M. Sevick-Muraca, and C. Li, "Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts," Cancer Res. 63, 7870-7875 (2003).
24. S. Gottschalk, O. L. Edwards, U. Sili, M. H. Huls, T. Goltsova, A. R. Davis, H. E. Heslop, and C. M. Rooney, "Generating CTLs against the subdominant Epstein-Barr virus LMPI antigen for the adoptive immunotherapy of EBV-associated malignancies," Blood 101, 1905-1912 (2003).
25. S. Kwon, S. Ke, J. P. Houston, W Wang, Q. Wu, C. Li, and E. M. Sevick-Muraca, "Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to αvB3 receptor expressed in Kaposi's sarcoma," Mol. Imaging 4, 75-87 (2005).
26. K. E. Adams, S. Ke, S. Kwon, F. Liang, Z. Fan, Y. Lu, K Hirschi, M. E. Mawad, M. A. Barry, and E. M. Sevick-Muraca, "Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer," J. Biomed. Opt. 12, 024017 (2007).
27. A. M. Leen, U. Sili, B. Savoldo, A. M. Jewell, P. A. Piedra, M. K Brenner, and C. M. Rooney, "Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications," Blood 103, 1011-1019 (2003).
28. C. Hess, T. K. Means, P. Autissier, T. Woodberry, M. Altfeld, M. M. Addo, N. Frahm, C. Brander, B. D. Walker, and A. D. Luster, "IL-8 responsiveness defines a subset of CD8 T cells poised to kill," Blood 104, 3463-3471 (2004).123